These results are consistent with our previous finding that obesity-mediated Ca2+-PIPs prevent membrane localization of AKT PH domains in vivo15 and suggest that candesartan inhibits the formation of obesity-mediated Ca2+-PIPs, leading to improved insulin signaling. Here, INS is linked to obesity disorder.